Genmab Announces Data to be Presented at 2017 ASCO Annual Meeting
April 20, 2017 10:11 ET
|
Genmab A/S
Media Release
8 abstracts on Genmab programs scheduled for presentation at ASCO
Two daratumumab oral presentations and five daratumumab poster presentations
Copenhagen, Denmark; April...
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2017
April 18, 2017 06:55 ET
|
Genmab A/S
Company Announcement
Net sales of DARZALEX in the first quarter of 2017 totaled USD 255 million
Genmab will receive royalties on worldwide net sales from Janssen Biotech,...
Selskabsvedtægter for Genmab A/S
April 05, 2017 08:30 ET
|
Genmab A/S
Selskabsvedtægter for Genmab A/S dateret den 4. april 2017 er blevet offentliggjort. Selskabsvedtægterne er tilgængelige på Genmabs hjemmeside:...
Articles of Association for Genmab A/S
April 05, 2017 08:30 ET
|
Genmab A/S
Genmab A/S has published its Articles of Association dated April 4, 2017. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm
Contact:
Rachel Curtis...
Capital Increase in Genmab as a Result of Employee Warrant Exercise
April 04, 2017 12:14 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; April 4, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 176,843 shares as a consequence of the exercise of employee...
Selskabsvedtægter for Genmab A/S
April 03, 2017 12:53 ET
|
Genmab A/S
Selskabsvedtægter for Genmab A/S dateret den 29. marts 2017 er blevet offentliggjort. Selskabsvedtægterne er tilgængelige på Genmabs hjemmeside:...
Articles of Association for Genmab A/S
April 03, 2017 12:53 ET
|
Genmab A/S
Genmab A/S has published its Articles of Association dated March 29, 2017. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm
Contact:
Rachel Curtis...
Fase II studie med daratumumab til behandling af non-Hodgkin lymfom videreføres ikke til del 2
March 30, 2017 12:29 ET
|
Genmab A/S
Selskabsmeddelelse
Fase II studiet (CARINA, LYM2001) i NHL videreføres ikke
Øvrige igangværende og planlagte studier med daratumumab til behandling af lymfomer og andre kræftformer end...
Phase II Study of Daratumumab in Non-Hodgkin’s Lymphoma Will Not Proceed to Stage 2 of Trial
March 30, 2017 12:29 ET
|
Genmab A/S
Company Announcement
Phase II study (CARINA, LYM2001) in NHL will not proceed
Other ongoing and planned studies with daratumumab in lymphomas and other cancers outside multiple myeloma...
Grant of Restricted Stock Units to two new Board Members and Grant of Restricted Stock Units and Warrants to the new Member of Management in Genmab
March 29, 2017 13:05 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; March 29, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that at a board meeting the board decided to grant 5,042 restricted stock units to...